-
1.发明公开公开(公告)号：US20240254155A1
公开(公告)日：2024-08-01
申请号：US18564361
申请日：2022-05-04
Inventor： Hyung Won RYU , Su Ui LEE , Sei-Ryang OH , Jae-Won LEE , Doo-Young KIM , Hyun-Jae JANG , Mun-Ock KIM , Seong Hun JEONG
IPC: C07H15/256 , A61K31/704 , A61K36/21 , A61P11/06 , A61P29/00 , C07H1/08
CPC classification number: C07H15/256 , A61K31/704 , A61K36/21 , A61P11/06 , A61P29/00 , C07H1/08 , A61K2236/33 , A61K2236/55
Abstract: The present invention relates to a novel compound isolated from spinach, and a composition comprising same for preventing or treating inflammatory diseases, and, more particularly, to a novel medicagenic acid glycoside compound isolated from spinach, a preparation method therefor, and a composition comprising same for preventing or treating inflammatory diseases.
-
2.发明申请Novel Indole Derivative or Pharmaceutically Acceptable Salt Thereof, Preparation Method Thereof, and Pharmaceutical Composition for Preventing or Treating Metabolic Diseases Containing Same as Active Ingredient 有权新型吲哚衍生物或其药学上可接受的盐，其制备方法和用于预防或治疗与活性成分相同的代谢疾病的药物组合物公开(公告)号：US20140057909A1
公开(公告)日：2014-02-27
申请号：US14070683
申请日：2013-11-04
Inventor： Hyun Sun LEE , Mun-Ock KIM , Yongseok CHOI , Kyeong Lee , Jeong-Jun PARK , Jee-Hee SEO , Hwayoung JUNG , Sungchan CHO
IPC: C07D401/12 , C07D295/155 , C07D209/20
CPC classification number: C07D401/12 , C07D209/12 , C07D209/14 , C07D209/20 , C07D209/26 , C07D295/155
Abstract: The present invention relates to an indole derivative, The indole derivative according to the present invention effectively inhibits the activity of diacylglycerol acyltransferase (DGAT) which induces metabolic diseases, such as obesity, diabetes, hyperlipidemia, or fatty liver and the like in lipid metabolism, thereby effectively regulating lipid metabolism and energy metabolism, and thus can be useful in pharmaceutical compositions for preventing or treating metabolic disease.
Abstract translation: 本发明涉及吲哚衍生物本发明的吲哚衍生物有效抑制二脂酰甘油酰基转移酶（DGAT）在脂质代谢中引起代谢性疾病如肥胖，糖尿病，高脂血症或脂肪肝等的活性， 从而有效地调节脂质代谢和能量代谢，因此可用于预防或治疗代谢疾病的药物组合物。
-
公开(公告)号：US20240261356A1
公开(公告)日：2024-08-08
申请号：US18290222
申请日：2022-05-11
Inventor： Su Ui LEE , Mun-Ock KIM , Hyung Won RYU , Sei-Ryang OH , Doo-Young KIM , Jae-Won LEE
IPC: A61K36/254 , A61K31/191 , A61K31/365 , A61K36/38 , A61P1/16
CPC classification number: A61K36/254 , A61K31/191 , A61K31/365 , A61K36/38 , A61P1/16 , A61K2236/39
Abstract: The present invention relates to a composition containing extracts from Garcinia cambogia and Acanthopanax for prevention or treatment of liver diseases and, more specifically, to a composition for prevention or treatment of liver disease, the composition containing, as active ingredients, (i) a Garcinia cambogia extract, hydroxycitric acid (HCA), or a derivative of hydroxycitric acid; and (ii) an Acanthopanax extract, Chiisanogenin, or a derivative of Chiisanogenin.
-
-
Search Results
3
records
(took 0.015 seconds)
